Franklin Resources Inc Sage Therapeutics, Inc. Transaction History

Franklin Resources Inc

$356 Billion
Q2 2025

A detailed history of Franklin Resources Inc transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 144,917 shares of SAGE stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

144,917

Holding current value

$1.26 Million

% of portfolio

0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$6.38 - $9.3 $924,570 - $1.35 Million	144,917 New	144,917 $1.32 Million
Q2 2023 Aug 11, 2023	SELL	$40.65 - $59.54 $1,991 - $2,917	-49 Reduced 0.02%	301,674 $14.2 Million
Q1 2023 May 12, 2023	SELL	$37.27 - $46.57 $5,627 - $7,032	-151 Reduced 0.05%	301,723 $12.7 Million
Q4 2022 Feb 10, 2023	SELL	$32.2 - $43.61 $5,119 - $6,933	-159 Reduced 0.05%	301,874 $11.5 Million
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $7,230 - $9,692	224 Added 0.07%	302,033 $11.8 Million
Q2 2022 Aug 11, 2022	BUY	$27.52 - $37.99 $2,229 - $3,077	81 Added 0.03%	301,809 $9.75 Million
Q1 2022 May 13, 2022	BUY	$30.71 - $45.71 $311,645 - $463,865	10,148 Added 3.48%	301,728 $9.99 Million
Q4 2021 Feb 11, 2022	BUY	$37.06 - $47.11 $34,651 - $44,047	935 Added 0.32%	291,580 $12.4 Million
Q3 2021 Nov 12, 2021	BUY	$40.26 - $57.37 $737,200 - $1.05 Million	18,311 Added 6.72%	290,645 $12.9 Million
Q2 2021 Aug 13, 2021	BUY	$54.88 - $79.29 $1.15 Million - $1.66 Million	20,949 Added 8.33%	272,334 $15.5 Million
Q1 2021 May 13, 2021	BUY	$70.65 - $96.76 $17,238 - $23,609	244 Added 0.1%	251,385 $18.8 Million
Q4 2020 Feb 10, 2021	BUY	$58.41 - $89.06 $3,446 - $5,254	59 Added 0.02%	251,141 $21.7 Million
Q3 2020 Nov 12, 2020	BUY	$41.13 - $62.45 $510,135 - $774,567	12,403 Added 5.2%	251,082 $15.3 Million
Q1 2020 May 13, 2020	SELL	$26.15 - $77.24 $16.6 Million - $49.1 Million	-635,430 Reduced 72.69%	238,679 $6.86 Million
Q4 2019 Feb 12, 2020	SELL	$60.18 - $154.77 $10.3 Million - $26.6 Million	-171,848 Reduced 16.43%	874,109 $63.1 Million
Q3 2019 Nov 14, 2019	SELL	$140.29 - $189.96 $176,063 - $238,399	-1,255 Reduced 0.12%	1,045,957 $147 Million
Q2 2019 Aug 14, 2019	SELL	$157.85 - $183.09 $308,123 - $357,391	-1,952 Reduced 0.19%	1,047,212 $192 Million
Q1 2019 May 14, 2019	BUY	$89.33 - $163.65 $554,649 - $1.02 Million	6,209 Added 0.6%	1,049,164 $167 Million
Q4 2018 Feb 12, 2019	BUY	$81.94 - $139.71 $7.55 Million - $12.9 Million	92,182 Added 9.7%	1,042,955 $99.9 Million
Q3 2018 Nov 13, 2018	BUY	$138.11 - $169.04 $52.4 Million - $64.1 Million	379,121 Added 66.32%	950,773 $134 Million
Q2 2018 Aug 14, 2018	BUY	$140.36 - $175.76 $11.1 Million - $13.9 Million	79,241 Added 16.09%	571,652 $89.5 Million
Q1 2018 May 10, 2018	SELL	$152.15 - $192.33 $4.9 Million - $6.19 Million	-32,179 Reduced 6.13%	492,411 $79.3 Million
Q4 2017 Feb 14, 2018	BUY	$60.72 - $167.34 $3.05 Million - $8.41 Million	50,254 Added 10.59%	524,590 $86.4 Million
Q3 2017 Nov 13, 2017	BUY	$61.4 - $88.52 $29.1 Million - $42 Million	474,336	474,336 $29.6 Million

Others Institutions Holding SAGE

# of Institutions

215

Shares Held

50.1M

Call Options Held

790K

Put Options Held

440K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $516M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Sage Therapeutics, Inc. Transaction History